1
Return

Rethinking Progression in Hepatocellular Carcinoma: Is Oligoprogression a Window for Local Ablation?

delete2026-06-11
delete0
PRE
AI
H
Hisashi Hidaka *
DOI：10.1111/hepr.70218delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
Keywords:
atezolizumab
bevacizumab (atez/bev)
hepatocellular carcinoma (HCC)
immune checkpoint inhibition
immunogenic cell death (ICD)
local ablation therapy

Journal

Hepatology Research cover
Hepatology Research
IF:
3.4
Papers:
4.2K
Citations:
4.9K

Organization

K
kitasato university
Scholars:
1.2K
Papers: 365
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers